Iqvia Holdings Inc. SEC filings IQV
Iqvia Holdings Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Dec 11, 2013. Its latest annual report, Form ARS, was filed on Feb 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Feb 27, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 17, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Feb 28, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 13, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Feb 23, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 15, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 15, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 16, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 12, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 18, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 19, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 16, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Feb 16, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 11, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | Mar 24, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Feb 12, 2015 | Dec 31, 2014 |
| ARS | Annual report to shareholders | Apr 1, 2014 | Dec 31, 2013 |
| 10-K/A | Amended annual report | Feb 21, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Feb 13, 2014 | Dec 31, 2013 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- IQV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1478242
- Former names
- Quintiles IMS Holdings, Inc. (until Nov 3, 2017); Quintiles Transnational Holdings Inc. (until Sep 22, 2016)
Other Services-Commercial Physical & Biological Research companies
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.